ManagementNSE SME · ONYX
Onyx Biotec Limited
Committee Meeting Updates
01 / The disclosure
What the company shared
Onyx Biotec Limited has Submitted to the Exchange the outcome of the meeting of the committee of the Independent Directors held today i.e. October 07, 2026 to give their recomendation in the Open Offer of Onyx Biotec Limited in compliance with Regulation 26(7) of the SEBI (SAST) Regulations, 2011and subsequent Amendments thereto.
Exchange-provided summary Company profile
A question for your research
Check the role, effective date, stated reason and succession arrangements.
The evidence
Read the source excerpts
PDF text extraction is queued. The summary above comes from the exchange listing.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106810190
- First collected
- 7 Oct 2026, 21:05 IST
- PDF extraction
- pending
You’ve reached the end of this disclosure.